Cargando…

Editorial: Mechanisms of Novel Drugs and Gene Modifiers in the Treatment of Cystic Fibrosis

Detalles Bibliográficos
Autores principales:	Veit, Guido, Silva, Iris, Conese, Massimo, Laselva, Onofrio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315944/ https://www.ncbi.nlm.nih.gov/pubmed/35903150 http://dx.doi.org/10.3389/fmolb.2022.975946

Ejemplares similares

Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells
por: Laselva, Onofrio, et al.
Publicado: (2022)

Elexacaftor/Tezacaftor/Ivacaftor Accelerates Wound Repair in Cystic Fibrosis Airway Epithelium
por: Laselva, Onofrio, et al.
Publicado: (2022)

Anti-Inflammatory and Anti-Oxidant Effect of Dimethyl Fumarate in Cystic Fibrosis Bronchial Epithelial Cells
por: Laselva, Onofrio, et al.
Publicado: (2021)

Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
por: Arif, Sheikh Mohammed, et al.
Publicado: (2022)

Editorial: Targeting glioblastoma: Mechanisms of pathology and novel therapeutic strategies
por: Kusaczuk, Magdalena, et al.
Publicado: (2023)

Editorial: Novel Molecular Mechanisms and Innovative Therapeutic Approaches for Age-Associated Diseases
por: Sun, Leming, et al.
Publicado: (2022)

Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis
por: Silva, Iris A. L., et al.
Publicado: (2022)

Editorial: Mechanisms of Fluorescent Proteins
por: Fang, Chong, et al.
Publicado: (2021)

Nanotechnology in Drug Delivery for Liver Fibrosis
por: Gu, Lihong, et al.
Publicado: (2022)

Editorial: Oxidative stress in degenerative bone and joint diseases: novel molecular mechanisms and therapeutic potential
por: Lin, Jialiang, et al.
Publicado: (2023)

Novel Therapeutic Targets in Liver Fibrosis
por: Zhang, Jinhang, et al.
Publicado: (2021)

Principles and functions of condensate modifying drugs
por: Patel, Avinash, et al.
Publicado: (2022)

SLC6A14 Impacts Cystic Fibrosis Lung Disease Severity via mTOR and Epithelial Repair Modulation
por: Mercier, Julia, et al.
Publicado: (2022)

The Expression of AQP1 IS Modified in Lung of Patients With Idiopathic Pulmonary Fibrosis: Addressing a Possible New Target
por: Galán-Cobo, Ana, et al.
Publicado: (2018)

Editorial: Type I Chaperonins: Mechanism and Beyond
por: Breiman, Adina, et al.
Publicado: (2018)

Editorial: Molecular Dynamics and Machine Learning in Drug Discovery
por: Decherchi, Sergio, et al.
Publicado: (2021)

Editorial: Novel advances in gastrointestinal cancer treatment
por: Liu, Yanqing, et al.
Publicado: (2023)

Editorial: Understanding Protein Dynamics, Binding and Allostery for Drug Design
por: Hu, Guang, et al.
Publicado: (2021)

Editorial: mRNA Translational Control as a Mechanism of Post-transcriptional Gene Regulation
por: Kiss, Daniel L., et al.
Publicado: (2022)

Editorial: Novel aspects of the immunological and structural barrier of the epidermis
por: O’Shaughnessy, Ryan, et al.
Publicado: (2023)

Editorial: Novel approaches to study metals in molecular biology
por: Padilla-Benavides, Teresita, et al.
Publicado: (2023)

Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression
por: Wang, Jiayu, et al.
Publicado: (2022)

Editorial: Bacterial Mechanisms of Antibiotic Resistance: A Structural Perspective
por: Conn, Graeme L., et al.
Publicado: (2019)

Editorial: Oligomerization and fibrillation of amyloid peptides: Mechanism, toxicity and inhibition
por: Qian, Zhenyu, et al.
Publicado: (2022)

Editorial: Chronic Liver Disease: New Targets and New Mechanisms
por: Ye, Yanting, et al.
Publicado: (2022)

Editorial: Computational Approaches to Study the Impact of Mutations on Disease and Drug Resistance
por: Ben-Tal, Nir, et al.
Publicado: (2021)

Editorial: Venom Peptides: A Rich Combinatorial Library for Drug Development
por: Cardoso, Fernanda C., et al.
Publicado: (2022)

Editorial: Drug Delivery System Based on Nanoparticles for Inflammation and Cancer Therapy
por: Zhang, Mingxin, et al.
Publicado: (2022)

Editorial: Integration of structural biology data in lead drug discovery and optimization
por: Roversi, Pietro, et al.
Publicado: (2023)

Lentiviral Vectors and Cystic Fibrosis Gene Therapy
por: Castellani, Stefano, et al.
Publicado: (2010)

Editorial: Characterization, Biosynthesis and Biological Functions of Novel Glyco-Epitopes
por: Yan, Shi, et al.
Publicado: (2022)

Editorial: Novel approaches aiming to overcome current nanomedicine limitations
por: Palomba, Roberto, et al.
Publicado: (2023)

Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
por: Zhao, Yuan-Quan, et al.
Publicado: (2023)

Editorial: “Small molecules targeting transmembrane receptors and ion channels in drug discovery”
por: Vitale, Rosa Maria, et al.
Publicado: (2023)

Editorial: RNAs at the crossroads between effectors and targets; discovery and development of new drugs
por: Chiappori, Federica, et al.
Publicado: (2023)

Editorial: Molecular Mechanisms Involved in Heart Failure, Parkinson’s, and Alzheimer’s Diseases
por: Femminella, Grazia Daniela, et al.
Publicado: (2021)

Editorial: Nucleic Acid Polymerases: The Two-Metal-Ion Mechanism and Beyond
por: Pata, Janice D., et al.
Publicado: (2022)

Human Amniotic Mesenchymal Stem Cells and Fibroblasts Accelerate Wound Repair of Cystic Fibrosis Epithelium
por: Beccia, Elisa, et al.
Publicado: (2022)

Editorial: Bioactive sphingolipids in health and disease
por: Aslan, Mutay, et al.
Publicado: (2022)

Treatment of Polarized Cystic Fibrosis Airway Cells With HGF Prevents VX-661-Rescued F508del-CFTR Destabilization Caused by Prolonged Co-exposure to VX-770
por: Matos, Ana M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6klpcrr7ip0vr8avg4ni9ma09m